Topical herbal extract (Huangdang mixture) exhibits both preventive and therapeutic effects in murine acute irritant contact dermatitis

Background  Contact dermatitises, including allergic contact dermatitis and irritant contact dermatitis, are among the most common skin disorders in humans. Chinese herbal medicines (CHM) have been used in treating contact dermatitises for centuries. Systemic administration of CHM, including ingredients in Huangdang mixture containing Chinese angelica, Radix Paeonlae rubra, cat nut, and phelloden dron, rhizoma alismatis, rhizoma smilacis glabrae, and rhizome of swordlike, improves allergic contact dermatitis induced by l‐fluoro‐2,4‐dinitrobenzene. Whether topical applications of these herbal extracts display preventive and/or therapeutic effects on contact dermatitis, thereby avoiding the potential side effects of systemic CHM, remains largely unknown.

[1]  Jun-Rong Du,et al.  Z-ligustilide attenuates lipopolysaccharide-induced proinflammatory response via inhibiting NF-κB pathway in primary rat microglia , 2010, Acta Pharmacologica Sinica.

[2]  V. Pavlovic,et al.  Low‐dose cyclosporine A therapy increases the regulatory T cell population in patients with atopic dermatitis , 2009, Allergy.

[3]  P. Elias,et al.  The role of CD44 in cutaneous inflammation , 2009, Experimental dermatology.

[4]  J. Sundberg,et al.  Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. , 2009, The Journal of allergy and clinical immunology.

[5]  P. Elias,et al.  Topical calcineurin inhibitors compromise stratum corneum integrity, epidermal permeability and antimicrobial barrier function , 2009, Experimental dermatology.

[6]  Ying-yong Zhao,et al.  Simultaneous determination of eight major steroids from Polyporus umbellatus by high-performance liquid chromatography coupled with mass spectrometry detections. , 2009, Biomedical chromatography : BMC.

[7]  A. Gottlieb,et al.  Lichen planus-like eruptions: an emerging side effect of tumor necrosis factor-alpha antagonists. , 2009, Journal of the American Academy of Dermatology.

[8]  M. Burch,et al.  Tacrolimus in pediatric heart transplantation: ameliorated side effects in the steroid‐free, statin era , 2009, Clinical transplantation.

[9]  M. Weichenthal,et al.  Different effects of pimecrolimus and betamethasone on the skin barrier in patients with atopic dermatitis. , 2009, The Journal of allergy and clinical immunology.

[10]  Sang-Wan Seo,et al.  Oral administration of Uncariae rhynchophylla inhibits the development of DNFB-induced atopic dermatitis-like skin lesions via IFN-gamma down-regulation in NC/Nga mice. , 2009, Journal of ethnopharmacology.

[11]  M. Lima,et al.  Cyclosporine-induced parkinsonism , 2009, Journal of Neurology.

[12]  Mian Zhang,et al.  [Chemical constituents of Alisma orientalis and their immunosuppressive function]. , 2009, Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi = China journal of Chinese materia medica.

[13]  S. Tanabe,et al.  Fermented Barley Extract Suppresses the Development of Atopic Dermatitis-Like Skin Lesions in NC/Nga Mice, Probably by Inhibiting Inflammatory Cytokines , 2009, Bioscience, biotechnology, and biochemistry.

[14]  S. Miyagi,et al.  Parkinsonism during cyclosporine treatment in liver transplantation: an unusual case report. , 2008, Transplantation proceedings.

[15]  A. D. de Queiroz,et al.  Gingival overgrowth in a renal transplant recipient using cyclosporine A. , 2008, Journal of dentistry for children.

[16]  P. Elias,et al.  Chinese herbal medicine (Tuhuai extract) exhibits topical anti‐proliferative and anti‐inflammatory activity in murine disease models , 2008, Experimental dermatology.

[17]  S. Jacob.  Ciclosporin ophthalmic emulsion – a novel therapy for benzyl alcohol‐associated eyelid dermatitis , 2008, Contact dermatitis.

[18]  M. D. de Bruin‐Weller,et al.  Cyclosporin A Treatment Is Associated with Increased Serum Immunoglobulin E Levels in a Subgroup of Atopic Dermatitis Patients , 2007, Dermatitis : contact, atopic, occupational, drug.

[19]  Su-Jin Lee,et al.  Oral administration of Astragalus membranaceus inhibits the development of DNFB-induced dermatitis in NC/Nga mice. , 2007, Biological & pharmaceutical bulletin.

[20]  Y. Ukawa,et al.  Oral administration of the extract from Hatakeshimeji (Lyophyllum decastes sing.) mushroom inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice. , 2007, Journal of nutritional science and vitaminology.

[21]  M. Röcken,et al.  Calcineurin inhibitors and rapamycin: cancer protection or promotion? , 2007, Experimental dermatology.

[22]  W. Wei,et al.  Effects and mechanisms of Paeoniflorin, a bioactive glucoside from paeony root, on adjuvant arthritis in rats , 2007, Inflammation Research.

[23]  C. Paul,et al.  Risk of lymphoma following exposure to calcineurin inhibitors and topical steroids in patients with atopic dermatitis. , 2007, The Journal of investigative dermatology.

[24]  Wei Wei,et al.  Effects and mechanisms of total glucosides of paeony on adjuvant arthritis in rats. , 2007, Journal of ethnopharmacology.

[25]  Mark Avigan,et al.  Hepatosplenic T cell lymphoma associated with infliximab use in young patients treated for inflammatory bowel disease. , 2007, Journal of pediatric gastroenterology and nutrition.

[26]  M. Bagot,et al.  Psoriasis induced by tumor necrosis factor-alpha antagonist therapy: a case series. , 2007, The Journal of rheumatology.

[27]  M. D. de Bruin‐Weller,et al.  Efficacy and safety of long‐term treatment with cyclosporin A for atopic dermatitis , 2007, Journal of the European Academy of Dermatology and Venereology : JEADV.

[28]  J. Um,et al.  Inhibitory effects of Rumex japonicus Houtt. on the development of atopic dermatitis‐like skin lesions in NC/Nga mice , 2006, The British journal of dermatology.

[29]  K. Kragballe,et al.  A 52‐week randomized safety study of a calcipotriol/betamethasone dipropionate two‐compound product (Dovobet®/Daivobet®/Taclonex®) in the treatment of psoriasis vulgaris , 2006, The British journal of dermatology.

[30]  Yunfeng Zhou,et al.  Chinese medicine Angelica sinensis suppresses radiation-induced expression of TNF-α and TGF-β1 in mice , 2006 .

[31]  M. Kumaran,et al.  Effect of topical calcipotriol, betamethasone dipropionate and their combination in the treatment of localized vitiligo , 2006, Journal of the European Academy of Dermatology and Venereology : JEADV.

[32]  E. Choi,et al.  Effects of a multilamellar emulsion on glucocorticoid‐induced epidermal atrophy and barrier impairment , 2006, The Journal of dermatology.

[33]  M. Rich,et al.  Infliximab-induced Headache and Infliximab-induced Meningitis: Two Ends of the Same Spectrum? , 2005, Southern medical journal.

[34]  G. Schuler,et al.  Infliximab in the treatment of moderate to severe atopic dermatitis. , 2005, Journal of the American Academy of Dermatology.

[35]  M. V'lckova-Laskoska,et al.  Cyclosporin A-induced gingival hyperplasia in psoriasis: review of the literature and case reports. , 2005, Acta dermatovenerologica Croatica : ADC.

[36]  M. Scaff,et al.  Cyclosporine A-induced ocular opsoclonus and reversible leukoencephalopathy after orthotopic liver transplantation: brief report. , 2004, Clinical neuropharmacology.

[37]  K. Kohno,et al.  Oral administration of royal jelly inhibits the development of atopic dermatitis-like skin lesions in NC/Nga mice. , 2003, International immunopharmacology.

[38]  Qiang Xu,et al.  Immunomodulatory activity of the aqueous extract from rhizome of Smilax glabra in the later phase of adjuvant-induced arthritis in rats. , 2003, Journal of ethnopharmacology.

[39]  P. Elias,et al.  Short-term glucocorticoid treatment compromises both permeability barrier homeostasis and stratum corneum integrity: inhibition of epidermal lipid synthesis accounts for functional abnormalities. , 2003, The Journal of investigative dermatology.

[40]  S. Rogers,et al.  Adverse effects with long‐term cyclosporin for severe psoriasis , 2002, Clinical and experimental dermatology.

[41]  A. Kligman,et al.  Corticosteroid‐induced atrophy and barrier impairment measured by non‐invasive methods in human skin , 2001, Skin research and technology : official journal of International Society for Bioengineering and the Skin (ISBS) [and] International Society for Digital Imaging of Skin (ISDIS) [and] International Society for Skin Imaging.

[42]  D. Laufer,et al.  Cyclosporine A-induced gingival hyperplasia pemphigus vulgaris: literature review and report of a case. , 2000, Journal of periodontology.

[43]  Kirby,et al.  Gingival hyperplasia in psoriasis patients treated with cyclosporin , 2000, Clinical and experimental dermatology.

[44]  M. Boguniewicz,et al.  A randomized, vehicle-controlled trial of tacrolimus ointment for treatment of atopic dermatitis in children. Pediatric Tacrolimus Study Group. , 1998, The Journal of allergy and clinical immunology.

[45]  Xiran Lin,et al.  The Effects of 4 Traditional Chinese Medicinal Compounds on Murine DNFB Dermatitis , 1998 .

[46]  Porter,et al.  Renal function after 10 years' treatment with cyclosporin for psoriasis , 1998, The British journal of dermatology.

[47]  T. Bieber,et al.  A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group. , 1997, The New England journal of medicine.

[48]  T. Stoof,et al.  Sustained renal function loss in psoriasis patients after withdrawal of low‐dose cyclosporin therapy , 1992, The British journal of dermatology.

[49]  P. Elias,et al.  Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. , 2008, The Journal of investigative dermatology.

[50]  J. Um,et al.  Inhibitory effects of Saururus chinensis (LOUR.) BAILL on the development of atopic dermatitis-like skin lesions in NC/Nga mice. , 2008, Biological & pharmaceutical bulletin.

[51]  Wei Wei.  Effects and sectional mechanisms of total glucosides of paeony on mice with chronic dermatitis-eczema , 2008 .

[52]  Shang Jing-we.  Surveying the Curative Effect on the Ointment of Qi can Lian to Treat the Eczema of the Dermatitis , 2007 .

[53]  A. Remitz,et al.  Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children. , 2007, Acta dermato-venereologica.

[54]  B. Thiers.  Anti-Tumor Necrosis Factor Alpha-Induced Psoriasiform Eruptions: Three Further Cases and Current Overview , 2007 .

[55]  N. Cassano,et al.  Infliximab in recalcitrant severe atopic eczema associated with contact allergy. , 2006, International journal of immunopathology and pharmacology.

[56]  Yunfeng Zhou,et al.  Chinese medicine Angelica sinensis suppresses radiation-induced expression of TNF-alpha and TGF-beta1 in mice. , 2006, Oncology reports.

[57]  Y. Du.  Modulatory Effect of the Oral Liquid Expelling Wind and Stopping Itching on Th_1/Th_2 Cytokines in Patients with Dermatitis and Eczema , 2005 .

[58]  J. Auwerx,et al.  Topical Peroxisome Proliferator Activated Receptor-α Activators Reduce Inflammation in Irritant and Allergic Contact Dermatitis Models , 2002 .

[59]  R. Langley,et al.  Tacrolimus ointment for the treatment of atopic dermatitis in adult patients: part I, efficacy. , 2001, Journal of the American Academy of Dermatology.